A Single Center, Open-label Clinical Trial to Evaluate Pharmacokinetic Characteristics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women Volunteers
Latest Information Update: 11 Jun 2020
At a glance
- Drugs PBK-1801 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Pharmbio Korea
- 11 Jun 2020 New trial record